USF1 and diabetic kidney disease: It is considered that the activation of the TGF-β1 promoter by AP-1 transcription factor binding is not specific for diabetic nephropathy, whereas the transcription factor USF1 is specifically activated by high-glucose stimulation in diabetes mellitus and activates the TGF-β1 promoter.